Key result
Targeted nanoparticles delivering dual-action peptide reduce fibrosis and improve post-MI cardiac function in mice.
Why the study?
Do infarcted heart-targeting nanoparticles delivering a bifunctional anti-inflammatory and anti-fibrotic peptide improve cardiac repair and function in a mouse model of myocardial infarction?
Do infarcted heart-targeting nanoparticles delivering a bifunctional anti-inflammatory and anti-fibrotic peptide improve cardiac repair and function in a mouse model of myocardial infarction?
An intravenously delivered, MMP-responsive nanoparticle platform enables dual-target modulation of IL-1 inflammatory and TGF-β fibrotic pathways to promote cardiac repair after acute myocardial infarction in mice.
Answers are grounded in this paper and cite their sources.
Dual-target nanoparticles may coordinately modulate post-MI inflammation and fibrosis in models; leaves open clinical translation.
Following myocardial infarction (MI), excessive inflammation and maladaptive fibrosis synergistically drive adverse cardiac remodeling and progressive functional deterioration. Current therapeutic strategies targeting these pathological processes individually have shown limited efficacy, highlighting the need for approaches that coordinately regulate the post-infarction microenvironment. Here, we report an infarct-targeted nanoparticle platform for dual-target modulation of inflammatory and fibrotic signaling after MI. A bifunctional peptide, RYTVELAGGGGGPLGMWSRGGGGGECGLLPVGRPDRNVWRWLCK (RPE), was engineered by integrating a pathway-selective IL-1 receptor-targeting immunomodulatory domain and a TGF-β receptor II-targeting antifibrotic domain through a matrix metalloproteinase (MMP)-cleavable linker. Intact RPE possesses both anti-inflammatory and anti-fibrotic activities, while its MMP-responsive linker renders RPE susceptible to cleavage by the upregulated MMPs in the infarcted myocardium into the RYT and ECG domains, which can independently modulate IL-1 and TGF-β signaling, respectively. To allow rapid and safe delivery during the critical therapeutic window following MI (acute phase), RPE was encapsulated into intravenously deliverable, infarcted heart-targeting nanoparticles, enabling preferential accumulation and sustained release within the injured myocardium. In a mouse MI model, this platform significantly attenuated inflammatory responses, reduced myofibroblast formation and fibrotic remodeling, and enhanced neovascularization, resulting in marked improvement in cardiac function. These findings demonstrate an infarcted heart-targeting nanotherapeutic strategy for cardiac repair after acute MI through dual-target modulation of post-infarction inflammation and fibrosis. STATEMENT OF SIGNIFICANCE: Effective treatment of myocardial infarction remains challenging because excessive inflammation and fibrosis occur simultaneously but require coordinated regulation during the acute phase after injury. We developed a spatiotemporally controlled nanotherapeutic platform that combines infarcted heart-targeting nanoparticles with a microenvironment-responsive bifunctional peptide. Elevated matrix metalloproteinase activity in the infarcted myocardium activates the peptide, enabling site-specific and independent modulation of IL-1- and TGF-β-mediated inflammatory and fibrotic signaling. Intravenous delivery allows rapid treatment without direct myocardial injection while providing sustained therapeutic release in injured tissue. This strategy significantly improves cardiac repair by reducing inflammation and fibrosis, enhancing neovascularization, and improving cardiac function, providing a promising biomaterial-based approach for precision therapy after myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Guan et al. (2026) studied Myocardial infarction (mouse model). Infarcted heart-targeting nanoparticles delivering bifunctional peptide RPE (RYTVELAGGGGGPLGMWSRGGGGGECGLLPVGRPDRNVWRWLCK) was evaluated on Inflammatory responses, myofibroblast formation, fibrotic remodeling, neovascularization, and cardiac function. Infarct-targeted nanoparticles delivering bifunctional peptide RPE attenuated inflammation and fibrosis, enhanced neovascularization, and improved cardiac function in a mouse MI model.
Synapse has enriched 10 related papers. Consider them for comparative context: